COVID-19: Govt to allow industrial manufacturers to produce oxygen for medical use

Image
Press Trust of India New Delhi
Last Updated : Apr 07 2020 | 10:04 PM IST

The Drug Controller General of India (DCGI) has decided to grant licence to manufacturers of industrial oxygen to produce oxygen for medical use in public interest in the wake of the coronavirus outbreak.

The DGCI has asked all state and union territory drug controllers to take action for granting licence to manufacturers of industrial oxygen to make oxygen for medical use.

In a letter, the DCGI said that supplemental oxygen therapy is part of clinical management of COVID-19patients and therefore, it is imperative to ensure the availability and supply of oxygen medical use across the country.

He said that the All India Industrial Gases Manufactures' Association has proposed for allowing manufactures of industrial oxygen to produce for medical use.

"...to ensure the availability and supply of oxygen for medical use it has been decided in public interest that premises which are having facility to manufacture industrial oxygen should be granted manufacturing licence to manufacture oxygen for medical use within 24 hours of receiving the application, fees, etc. as per the Drugs and Cosmetics Act, 1940 and rules," the DGCI said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 07 2020 | 10:04 PM IST

Next Story